×
Please click
here
if you are not redirected within a few seconds.
All
News
Videos
Images
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
Yahoo Finance
EMERYVILLE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today that...
6 days ago
Mintz Advises Daré Bioscience in $22M Non-Dilutive Strategic Royalty and Revenue Interest Financing
Mintz
Mintz advised Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company focused on women's health, in a $22 million non-dilutive...
1 week ago
FDA Action Alert: ImmunityBio, Aquestive, XOMA and More
BioSpace
Aquestive Therapeutics is developing Libervant (diazepam) buccal film as an acute treatment for intermittent, stereotypic episodes of frequent...
1 month ago
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
GlobeNewswire
Earned $9 million milestone upon U.S. Food and Drug Administration's approval of Day One's OJEMDA™ (tovorafenib); XOMA is entitled to...
2 weeks ago
(XOMA) Investment Analysis
Stock Traders Daily
Sometimes Stocks Move Fast, and Xoma Corporation XOMA is no Exception.
5 days ago
XOMA (NASDAQ:XOMA) Shares Cross Above 200 Day Moving Average of $21.30
MarketBeat
XOMA Co. (NASDAQ:XOMA - Get Free Report)'s share price crossed above its 200-day moving average during trading on Friday .
2 days ago
Wilson Sonsini Advises Kinnate Biopharma on Acquisition By XOMA
Wilson Sonsini
On February 16, 2024, Kinnate Biopharma Inc., a clinical-stage precision oncology company, announced it has entered into a definitive merger...
3 months ago
XOMA Full Year 2022 Earnings: Revenues Beat Expectations, EPS In Line
Yahoo Movies Canada
XOMA ( NASDAQ:XOMA ) Full Year 2022 Results Key Financial Results Net loss: US$17.1m (down by 320% from US$7.79m profit...
1 day ago
XOMA Corporation Announces Closing of Tender Offer
GlobeNewswire
Following the closing of the tender offer, XOMA merged Kinnate with and into a subsidiary, XRA 1 Corp. (the “Merger”), and all shares of Kinnate...
1 month ago
Novartis Abandons Xoma-Partnered Antibody for Pancreatic Cancer
BioSpace
Novartis Abandons Xoma-Partnered Antibody for Pancreatic Cancer ... Novartis is discontinuing the development of the anti-TGFβ antibody NIS793 and...
8 months ago